Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/62793
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKamel, Buthaina-
dc.contributor.authorBachir, Wesam-
dc.contributor.authorEl-Daher, Moustafa Sayem-
dc.date.accessioned2023-10-19T05:20:49Z-
dc.date.available2023-10-19T05:20:49Z-
dc.date.issued2023-10-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/62793-
dc.description1040-1046en_US
dc.description.abstractIn this work we carried out theoretical evaluation of the potential use of BODIPY and related compounds as photosensitizer in photodynamic therapy (PDT). Five compounds bearing the chromophore of 4,4-difluoro-4-bora-3a,4a-diazas- indacene (BODIPY) with substituent elements from the fourth column in the periodic table (Si-Ge-Sn-Pb) have been investigated. In the present study the density functional theory and its time dependent extension TD-DFT have been used to calculate the energy of ground, singlet-triplet excited states and energy for  E s1 , E T2  o  S o   S  The electronic absorption spectra, transition dipole moments (TDM) for spin-allowed S0→Sn and other properties have been calculated. The results of this work show that among the studied compounds, PM-Sn is potentially the best option for photosensitizer in PDT.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.62(10) [October 2023]en_US
dc.subjectTD-DFTen_US
dc.subjectPDTen_US
dc.subjectBODIPYen_US
dc.subjectPhotosenstizersen_US
dc.subjectTDMen_US
dc.subjectElectronic absorption spectraen_US
dc.titleTheoretical investigation of BODIPY based compounds as photosensitizers in photodynamic therapyen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v62i10.6181en_US
Appears in Collections:IJC Vol.62(10) [October 2023]

Files in This Item:
File Description SizeFormat 
IJC 62 (10) 1040-1046.pdf1.04 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.